Publicação
Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category
| dc.contributor.author | Maes, Louise | |
| dc.contributor.author | Verschuere, Claudia | |
| dc.contributor.author | Walsh, Cathal | |
| dc.contributor.author | Weimar, Christian | |
| dc.contributor.author | Purroy, Francisco | |
| dc.contributor.author | Price, Christopher | |
| dc.contributor.author | Fonseca, Catarina | |
| dc.contributor.author | Hill, Michael D. | |
| dc.contributor.author | Jatuzis, Dalius | |
| dc.contributor.author | Kõrv, Janika | |
| dc.contributor.author | Kruuse, Christina | |
| dc.contributor.author | Mikulik, Robert | |
| dc.contributor.author | Nederkoorn, Paul | |
| dc.contributor.author | Czlonkowska, Anna | |
| dc.contributor.author | Fischer, Urs | |
| dc.contributor.author | McCormick, Michael | |
| dc.contributor.author | Castellanos, Maria | |
| dc.contributor.author | Baptista, Miguel | |
| dc.contributor.author | Marto, João Pedro | |
| dc.contributor.author | Thavanesan, Kamy | |
| dc.contributor.author | Williams, David J. | |
| dc.contributor.author | Kelly, Peter | |
| dc.contributor.author | Lemmens, Robin | |
| dc.contributor.institution | NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) | |
| dc.contributor.pbl | Oxford University Press | |
| dc.date.accessioned | 2026-05-06T10:26:02Z | |
| dc.date.available | 2026-05-06T10:26:02Z | |
| dc.date.issued | 2026-04 | |
| dc.description.version | publishersversion | |
| dc.description.version | published | |
| dc.format.extent | 1503081 | |
| dc.identifier.doi | 10.1093/esj/aakag033 | |
| dc.identifier.issn | 2396-9873 | |
| dc.identifier.other | PURE: 161923591 | |
| dc.identifier.other | PURE UUID: 1b698b3c-9f57-44e3-9387-0612caa70355 | |
| dc.identifier.other | Scopus: 105036905733 | |
| dc.identifier.other | PubMed: 42032972 | |
| dc.identifier.uri | http://hdl.handle.net/10362/202871 | |
| dc.identifier.url | https://www.scopus.com/pages/publications/105036905733 | |
| dc.language.iso | eng | |
| dc.peerreviewed | yes | |
| dc.subject | atherosclerotic cardiovascular disease | |
| dc.subject | colchicine | |
| dc.subject | risk estimation | |
| dc.subject | risk factors | |
| dc.subject | secondary prevention | |
| dc.subject | stroke | |
| dc.subject | transient ischaemic attack | |
| dc.subject | Clinical Neurology | |
| dc.subject | Cardiology and Cardiovascular Medicine | |
| dc.subject | SDG 3 - Good Health and Well-being | |
| dc.title | Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category | en |
| dc.title.subtitle | a secondary analysis of the CONVINCE randomised clinical trial | en |
| dc.type | journal article | |
| degois.publication.issue | 4 | |
| degois.publication.title | European Stroke Journal | |
| degois.publication.volume | 11 | |
| dspace.entity.type | Publication | |
| rcaap.rights | openAccess |
Ficheiros
Principais
1 - 1 de 1
